Epigenomics AG
ECX
Real-time TRADEGATE AG - 01/17 03:58:01 pm
1.82EUR
-0.98%
Prev.1.8020
Open1.7960
High1.8100
Low1.7960
Volume150
Financials
Sales 2018 3,79 M
EBIT 2018 -13,9 M
R. net 2018 -
Tréso. 2018 12,7 M
Rend. 2018 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales 2018 14,1x
EV / Sales 2019 5,17x
Capitalization 66,3 M
Company
Epigenomics AG is a Germany-based molecular diagnostics company focused on blood-based detection, prognosis and monitoring of cancers using deoxyribonucleic acid (DNA) methylation technology. It develops and commercializes blood-based diagnostic products across multiple cancer indications. The...
Sector :
Bio Diagnostics & Testing
Calendar :
2019-03-27 Earnings Release
Trading Rating : -
Investor Rating :
Latest news
01/11EPIGENOMICS AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
01/07EPIGENOMICS : Announces Positive Results from Microsimulation Model
PU
01/07EPIGENOMICS : Announces Positive Results from Microsimulation Model
EQ
01/02EPIGENOMICS AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
2018EPIGENOMICS : Announces Initiation of a Prospective Clinical Study for Liver Cancer Detection
EQ
2018EPIGENOMICS : Centers for Medicare & Medicaid Services issue official 2019 Clinical Lab Fee Schedule including Epi proColon(R)
EQ
2018EPIGENOMICS AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
2018EPIGENOMICS AG : Notification and public disclosure of transactions by persons
EQ